Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changes of ligand binding after membrane phosphorylation.

R Krulík1, P Bures, D Simůnková

  • 1Psychiatric Research Unit, Faculty of Medicine, Charles University, Praha, Czechoslovakia.

Drug Metabolism and Drug Interactions
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intergeneric hybrid origin of the invasive tetraploid Cirsium vulgare.

Plant biology (Stuttgart, Germany)·2024
Same author

Observation of Single-Top-Quark Production in Association with a Photon Using the ATLAS Detector.

Physical review letters·2023
Same author

Measurement of Suppression of Large-Radius Jets and Its Dependence on Substructure in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2023
Same author

Observation of the γγ→ττ Process in Pb+Pb Collisions and Constraints on the τ-Lepton Anomalous Magnetic Moment with the ATLAS Detector.

Physical review letters·2023
Same author

Strong Constraints on Jet Quenching in Centrality-Dependent p+Pb Collisions at 5.02 TeV from ATLAS.

Physical review letters·2023
Same author

Search for Heavy Neutral Leptons in Decays of W Bosons Using a Dilepton Displaced Vertex in sqrt[s]=13  TeV pp Collisions with the ATLAS Detector.

Physical review letters·2023

Phosphorylation of synaptic plasma membranes (SPM) reduces tricyclic antidepressant (TCA) binding in brain and lymphocytes. This phosphorylation affects TCA binding affinity, particularly for imipramine and desmethylimipramine, in various tissues.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Synaptic plasma membranes (SPM) play a crucial role in neurotransmitter reuptake.
  • Tricyclic antidepressants (TCAs) are widely used in treating depression and other psychiatric disorders.
  • The binding of TCAs to their targets is a key factor in their therapeutic efficacy.

Purpose of the Study:

  • To investigate the effect of phosphorylation on the binding of demethylated tricyclic antidepressants (TCA) to synaptic plasma membranes (SPM).
  • To examine how phosphorylation influences the affinity of specific radioligands like 3H-imipramine and 3H-desmethylimipramine.
  • To explore the impact of phosphorylation on TCA binding in different cellular membranes, including lymphocytes and platelets.

Main Methods:

  • Preparation of synaptic plasma brain membranes (SPM), lymphocyte membranes, and platelet membranes.

Related Experiment Videos

  • Incubation of membranes with phosphatidic acid or alpha-glycerolphosphate to induce phosphorylation.
  • Measurement of specific binding of demethylated tricyclic antidepressants (TCAs), including 3H-imipramine and 3H-desmethylimipramine.
  • Analysis of binding parameters, such as Bmax (maximum binding capacity) and Kd (dissociation constant).

    • Main Results:

    • Phosphorylation of SPM led to a significant decrease in the specific binding of demethylated TCAs.
    • The affinity of 3H-imipramine and 3H-desmethylimipramine binding to SPM was altered by phosphorylation.
    • Decreased TCA binding was also observed in lymphocyte membranes.
    • Platelet membranes showed reduced binding only for demethylated dibenzazepine derivatives.
    • Both Bmax and Kd values were decreased in the presence of phosphatidic acid or alpha-glycerolphosphate, indicating altered binding dynamics.

    Conclusions:

    • Phosphorylation is a critical regulatory mechanism affecting TCA binding to SPM and other cellular membranes.
    • These findings suggest that alterations in membrane phosphorylation could influence the pharmacokinetics and pharmacodynamics of TCAs.
    • Understanding these phosphorylation-dependent changes is important for optimizing TCA-based therapies and developing new antidepressant drugs.